Doctors and not pharmacies should retain control of any decision to switch a patient from a modern biologic medicine to a biosimilar version, the industry has argued. In its submission
Tag "biosimilar medicines"
The European Medicines Agency (EMA) and the European Commission have published an information guide for healthcare professionals on biosimilar medicines. Biosimilars are biological medicines that are highly similar in all essential aspects
Advertisements
